
Hard to keep up all the CV meetings? JCF has got ya for HF! Succinct meeting summaries #AHA2024 to follow soon 💠HFSA: onlinejcf.com/article/S1071-… 💠ESC: onlinejcf.com/article/S1071-… 💠ACC: onlinejcf.com/article/S1071-…

🩺🫀 HF & Transplant Fellow @Northwestern • Cardiac Amyloid #trained | @JCardFail FIT Editor

Hard to keep up all the CV meetings? JCF has got ya for HF! Succinct meeting summaries #AHA2024 to follow soon 💠HFSA: onlinejcf.com/article/S1071-… 💠ESC: onlinejcf.com/article/S1071-… 💠ACC: onlinejcf.com/article/S1071-…

Starting soon - don’t miss out! @AHAScience
🚨 Featured Science Alert! 🚨 Join us for “Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations.” 📅 Date: Mon, Nov 18 ⏰ Time: 9:45 AM - 11:00 AM (CST) 📍 Room: S103BC Don’t miss cutting-edge insights! 🔬❤️ #Cardiomyopathy #AHA24

🚨 Featured Science Alert! 🚨 Join us for “Amyloid, Hypertrophic, and Danon Cardiomyopathies: Targeted Therapies and Specific Populations.” 📅 Date: Mon, Nov 18 ⏰ Time: 9:45 AM - 11:00 AM (CST) 📍 Room: S103BC Don’t miss cutting-edge insights! 🔬❤️ #Cardiomyopathy #AHA24

Wasn’t ready for such an emotional session by @CardioNerds and Northwestern teams including @ThomasMDas @JennaSkowronski @ManingJennifer @AmitGoyalMD @SarahChuzi - outstanding discussion of the clinical challenges in ACHD VAD support, capstoned by patient himself #AHA2024

Don't miss "Heart-to-Heart: Insights from a Patient and Heart Team" at #AHA24! Explore the crossroads of adult congenital heart disease, AHF, and structural heart disease. 📆Sat, Nov 16 ⏰3:15 PM - 4:30 PM (Central) 📍Heart Theater I @CardioNerds @SarahChuzi @VorovichHeartMD

Next generation!! 🫀🤗 Proud of you!
This tweet is unavailable

Had fun giving talks on #HFpEF at the @HFSA board review course today. Made some "HFpEF connections" puzzles for the audience, in the style of @nytimes connections puzzles. See if you can figure it out! Match groups of 4 clues that are connected. connections.swellgarfo.com/g…

📢 📢🚨 A Must Read! 🫀🔬 This @JCardFail Review on the Management of OHCM thoroughly details the current treatment landscape, evidence limitations, and clinical application challenges Plus it is packed with clinical trial insights #cardiacmyosinmodulators #OHCM ☺️🤓

Even with protocols in place, there is room for bias in the heart transplant eval. We looked at all pts evaluated for HT at our 🏥 over 8 yrs. ⬇️ 1️⃣ Substance use cited as ineligibility factor in 151/1148 evaluated pts. Only 16 (‼️) of those pts went on to get HT!
How does race interact with substance use to impact eligibility for heart 🫀 transplantation? Check out our brief report 📝 led by @SarahChuzi out now in @TheJHLT. 👇🏾👇🏾👇🏾 jhltonline.org/article/S1053…

Grateful🙏🏾
We would like to give a huge congratulations to @JelaniGrantMD as the 2024 Silverman Award recipient! We look forward to his continued research regarding the use of incidental CAC to broaden CVD risk assessment

🚨Reviewer Mentoring Program FINAL CALL 🚨 🌟Expand your knowledge in peer review publishing and gain invaluable experience in reviewing academic papers. The deadline to apply for the program is 5/17. 🔗 Apply and learn more: bit.ly/3UE5djG app.storychief.io/videos/250…

🔥Out now in #JCF! This brief report shows that in the ongoing FINEARTS-HF trial, incorporating UACR reclassified kidney risk in 1/3 trial pts and US adults with HF, emphasizing the importance of albuminuria as part of comprehensive risk assessment. 🔗bit.ly/3UTfys8

Warm shoutout @WeAreNUHeart - outstanding synopses led by @ManingJennifer - special thnx @dranulala @robmentz - expert leadership; really fun to collate and then summarize all things #HF #ACC2024 - offering our views to the #HF community and especially all #FITs @ACCinTouch
Feel like CV meetings can be overwhelming?! The JCF team has “got ya” for HF insights. New offering - @JCardFail summarizes key new insights from CV meetings!! Check out ACC & ISHLT here: onlinejcf.com/article/S1071-… onlinejcf.com/article/S1071-…

Feel like CV meetings can be overwhelming?! The JCF team has “got ya” for HF insights. New offering - @JCardFail summarizes key new insights from CV meetings!! Check out ACC & ISHLT here: onlinejcf.com/article/S1071-… onlinejcf.com/article/S1071-…
Hey #FunctionNotFailure peeps! Don’t you wish someone would distill HF 🫀 clinical trials at #ACC24 in 1️⃣ spot? I know. Me too. 🙏🏽 @ManingJennifer @NMHheartdoc @HFpEF & team for 🧏🏽♀️ me!! @JCardFail 🔥EMPACT-MI 🔥ARISE 🔥STEP-HFPEF DM 🔥RELIEVE-HF 🔥DANGER 🔥IMPROVE HCM 🔥PRO-HF 🔥HOHZO onlinejcf.com/article/S1071-…

✨🫀 Such a pleasure collaborating on this piece with such a talented group! Invaluable perspectives 💜💜 @JCardFail
Hey #FunctionNotFailure peeps! Don’t you wish someone would distill HF 🫀 clinical trials at #ACC24 in 1️⃣ spot? I know. Me too. 🙏🏽 @ManingJennifer @NMHheartdoc @HFpEF & team for 🧏🏽♀️ me!! @JCardFail 🔥EMPACT-MI 🔥ARISE 🔥STEP-HFPEF DM 🔥RELIEVE-HF 🔥DANGER 🔥IMPROVE HCM 🔥PRO-HF 🔥HOHZO onlinejcf.com/article/S1071-…

Spectacular future leaders discussion panel with alums & friends of #Northwestern @NMCardioVasc @NorthwesternMed @NUFeinbergMed - breakthrough treatments; provocative new biology; future approaches #CVD.